Eris Lifesciences consolidates its stake in Swiss Parenterals
The proposed transaction will be effected as a share swap
The proposed transaction will be effected as a share swap
Lupin will address the observations and respond to the U.S. FDA within the stipulated timeframe
These certifications reflect the company's continuous commitment to maintaining international standards of environmental sustainability as well as occupational health and safety
The partnership will enable rapid and reliable product delivery
Glucagon-Like Peptide-1 is a natural hormone that regulates blood sugar, controls appetite, and slows digestion
The issue comprises a fresh issue of Rs. 95 crore and targeting a total raise of around Rs. 895 crore
EBITDA was Rs. 2,359.6 crore in the quarter ended September 30, 2025
SMDC is a participating authority under Pharmaceutical Inspection Cooperation Scheme (PIC/S)
Subscribe To Our Newsletter & Stay Updated